Sign In
Buy PTX
$0.0289
+0 (+0%)
At Close: Sep 17, 2019
PERNIX Signs Agreement to Acquire TREXIMET® Tablets for Migraine From GSK
07:30am, Wednesday, 14'th May 2014
MORRISTOWN, N.J.--(BUSINESS WIRE)--Pernix Therapeutics Holdings, Inc. (NASDAQ GM: PTX) (“Pernix” or the “Company”), a specialty pharmaceutical company, today announced that it has signed an ag
Pernix Therapeutics to Report First Quarter 2014 Financial Results on May 12, 2014
08:30am, Monday, 21'st Apr 2014
MORRISTOWN, N.J.--(BUSINESS WIRE)--Pernix Therapeutics Holdings, Inc. (NASDAQ: PTX), a specialty pharmaceutical company, today announced that it will release its first quarter 2014 financial results b
Pernix Therapeutics to Report Fourth Quarter and Full Year 2013 Financial Results on March 17, 2014
08:30am, Monday, 03'rd Mar 2014
HOUSTON--(BUSINESS WIRE)--Pernix Therapeutics Holdings, Inc. (NASDAQ: PTX), a specialty pharmaceutical company, today announced that it will release its fourth quarter and full year 2013 financial res
